The shares of Medtronic PLC (NYSE: MDT) are up 0.3% at $114.74 at last check, after J.P. Morgan Securities made the stock a large-cap pick for 2021 and hiked its price target to $130 from $122. The firm cited the company's new CEO and operating model, and a strong product pipeline.
On the charts, MDT is still climbing steadily toward pre-pandemic levels, up around 59% since March. Today's earlier pullback to $114 was caught by the 10-day moving average. Year-to-date, the equity is just above its year-to-date breakeven mark.
The majority of analysts are bullish on Medtronic stock, with 19 of the 21 in coverage at a "buy" or better rating. Furthermore, the 12-month consensus price target of $127.46 is an 11.4% premium to current levels.
That said, now could be a good time to speculate on MDT's next move with options. The stock's Schaeffer's Volatility Index (SVI) of 26% stands higher than just 13% of all other readings in its annual range, implying that options players are pricing in relatively low volatility expectations at the moment.
Comments
Log in or sign up to join the conversation.